{"id":"e1a9d3c6-454a-5aa4-9724-ab00244f78c3","stable_key":"c953cca8-774f-596d-b27a-f13c2c0b5fce:dhc-platelet-effect-not-trpv1","predicate":"inhibits","statement":"Inhibition of aggregation was not due to direct toxicity of these agents towards platelets as judged by LDH release, and the TRPV1 antagonist SB-452533 did not affect inhibition of ADP-induced platelet aggregation by capsaicin and N-oleoyldopamine.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"ed09c711-e14a-59af-8559-f3a60707a07e","mechanism_event_label":"The platelets were not simply being killed, and again the receptor is not the route.","subject":{"id":"6259a8e0-9611-5f60-9e1b-53bbd8eb1afd","slug":"dihydrocapsaicin","display_name":"Dihydrocapsaicin","entity_type_key":"small_molecule"},"object":{"id":"7b4963e9-6cbe-5340-b19c-5141bfd3b8b5","slug":"human-platelet-aggregation","display_name":"Human platelet aggregation, agonist specified","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"ed09c711-e14a-59af-8559-f3a60707a07e","stable_key":"c953cca8-774f-596d-b27a-f13c2c0b5fce:dhc-platelet-effect-not-trpv1-event","event_type":"observed_intervention","label":"The platelets were not simply being killed, and again the receptor is not the route.","description":"Inhibition of aggregation was not due to direct toxicity of these agents towards platelets as judged by LDH release, and the TRPV1 antagonist SB-452533 did not affect inhibition of ADP-induced platelet aggregation by capsaicin and N-oleoyldopamine.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"39f9446f-52a6-502d-b507-91137726f82c","slug":"arachidonic-acid","display_name":"AA","entity_type_key":"small_molecule"},"role":"agonist_used","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"8e0c61d8-3930-51d5-bce2-25a5edfb797c","slug":"human-trpv1","display_name":"Human transient receptor potential vanilloid 1 / TRPV1","entity_type_key":"protein"},"role":"excluded_mediator","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"6259a8e0-9611-5f60-9e1b-53bbd8eb1afd","slug":"dihydrocapsaicin","display_name":"Dihydrocapsaicin","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"7b4963e9-6cbe-5340-b19c-5141bfd3b8b5","slug":"human-platelet-aggregation","display_name":"Human platelet aggregation, agonist specified","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/dihydrocapsaicin-research/24953906.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"8d11f6733abf59c36bf8e2b6ed6f44f759cab3fdd209ff3c84c21b20e178a717\", \"start_char\": 0, \"end_char\": 1870, \"text_sha256\": \"8d11f6733abf59c36bf8e2b6ed6f44f759cab3fdd209ff3c84c21b20e178a717\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"In-vitro human platelet aggregation with agonist-specified stimulation and an LDH viability control","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Capsaicin and dihydrocapsaicin against the endogenous vanilloids N-oleoyldopamine and N-arachidonoyl-dopamine, with ADP, collagen and arachidonic acid as agonists","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The agonist-by-agonist design is what makes this useful: it separates the two plant compounds where a single-agonist study would have merged them. A TRPV1 antagonist control was included.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Dihydrocapsaicin research collection; topical membership is not evidence of a direct clinical effect, and dihydrocapsaicin is recorded separately from capsaicin.","comparator":null,"unit":null,"notes":"","entity":{"slug":"dihydrocapsaicin","display_name":"Dihydrocapsaicin","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The platelets were not simply being killed, and again the receptor is not the route.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[dhc-p24953906] Vanilloid-like agents inhibit aggregation of human platelets. (2014). https://pubmed.ncbi.nlm.nih.gov/24953906/ DOI: 10.1016/j.thromres.2014.05.038","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Platelets","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"48fdc6fb-a39d-53d3-b01a-eb40da3d5cb7","evidence_kind":"source_excerpt","locator":"Lines 166-177","start_line":166,"end_line":177,"excerpt":"### dhc-platelet-effect-not-trpv1\nInhibition of aggregation was not due to direct toxicity of these agents towards platelets as judged by LDH release, and the TRPV1 antagonist SB-452533 did not affect inhibition of ADP-induced platelet aggregation by capsaicin and N-oleoyldopamine.\nCondition category: normal\nnutrient_topic: Dihydrocapsaicin research collection; topical membership is not evidence of a direct clinical effect, and dihydrocapsaicin is recorded separately from capsaicin.\nplain_language: The platelets were not simply being killed, and again the receptor is not the route.\norganism: Human\ntissue_or_cell_type: Platelets\nexperimental_model: In-vitro human platelet aggregation with agonist-specified stimulation and an LDH viability control\nlimitations: The agonist-by-agonist design is what makes this useful: it separates the two plant compounds where a single-agonist study would have merged them. A TRPV1 antagonist control was included.\nexposure: Capsaicin and dihydrocapsaicin against the endogenous vanilloids N-oleoyldopamine and N-arachidonoyl-dopamine, with ADP, collagen and arachidonic acid as agonists\nevidence_span: {\"source_cache\": \"artifacts/dihydrocapsaicin-research/24953906.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"8d11f6733abf59c36bf8e2b6ed6f44f759cab3fdd209ff3c84c21b20e178a717\", \"start_char\": 0, \"end_char\": 1870, \"text_sha256\": \"8d11f6733abf59c36bf8e2b6ed6f44f759cab3fdd209ff3c84c21b20e178a717\"}\n[dhc-p24953906] Vanilloid-like agents inhibit aggregation of human platelets. (2014). https://pubmed.ncbi.nlm.nih.gov/24953906/ DOI: 10.1016/j.thromres.2014.05.038","model_system":"In-vitro human platelet aggregation with agonist-specified stimulation and an LDH viability control","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [dhc-p24953906] Vanilloid-like agents inhibit aggregation of human platelets. (2014). https://pubmed.ncbi.nlm.nih.gov/24953906/ DOI: 10.1016/j.thromres.2014.05.038","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"263a8425-969d-5a1b-8a9b-6101ba6a26a7","stable_key":"import-c953cca8-774f-596d-b27a-f13c2c0b5fce","title":"Dihydrocapsaicin: the second capsaicinoid, the hypothermia it is used to induce, what the gut and liver do to it, and what it does without TRPV1 (2026-09-21)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"97d90ff5dc65dc321068c3e2a0525585f32b2e17eb0c6bfa0d9ef26dc2d6c5a3","revision_id":"dbdc1ad7-a05a-579d-b2aa-c4348e3efc40","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}